ORPHA:585909
B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
Synonyms: B-ALL with t(9;22)(q34.1;q11.2) · BCR-ABL1-like B-ALL · Philadelphia chromosome-like B-ALL
- Type
- Etiological subtype
- Group
- Subtype of disorder
- Inheritance
- Not applicable
- Age of onset
- Adolescent, Adult, Childhood, Elderly, Infancy
- Status
- active
Orphadata ships no English definition for this code.
1
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) | B-ALL with t(9;22)(q34.1;q11.2) · BCR-ABL1-like B-ALL · Philadelphia chromosome-like B-ALL |
| fr | Leucémie/lymphome lymphoblastique B associé à t(9;22)(q34.1;q11.2) | Leucémie/lymphome lymphoblastique B avec t(9;22)(q34.1;q11.2) |
| de | B-lymphoblastische Leukämie/Lymphom mit t(9;22)(q34.1;q11.2) | Philadelphia-Chromosom-ähnliche B-ALL · B-ALL mit t(9;22)(q34.1;q11.2) · BCR-ABL1-ähnliche B-ALL |
| es | Leucemia/linfoma linfoblástico de células B con t(9;22)(q34.1;q11.2) | LLA-B con t(9;22)(q34.1;q11.2) · LLA-B similar a BCR-ABL1 · LLA-B similar al cromosoma Filadelfia |
| it | 'Leucemia linfoblastica a cellule B/linfoma con t(9;22)(q34.1;q11.2)' | LLA-B BCR-ABL1 simile · LLA-B con t(9;22)(q34.1;q11.2) · LLA-B cromosoma Philadelphia simile |
| nl | B-lymfoblastische leukemie/lymfoom met t(9;22)(q34.1;q11.2) | B-ALL met t(9;22)(q34.1;q11.2) · BCR-ABL1-achtige B-ALL · Philadelphia-chromosoomachtige B-ALL |
| pt | Leucemia/linfoma linfoblástico-B com t(9;22)(q34.1;q11.2) | |
| pl | Białaczka limfoblastyczna/chłoniak z komórek B z t(9;22)(q34.1;q11.2) | = en |
| cs | B-lymfoblastická leukémie/lymfom s t(9;22)(q34.1;q11.2) | = en |
| uk | В-лімфобластний лейкоз/лімфома з t(9;22)(q34.1;q11.2) | B-ALL з t(9;22)(q34.1;q11.2) · BCR-ABL1-подібний B-ALL · Філадельфійська хромосома B-ALL |
| zh | B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) | = en |
| tr | B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) | = en |
2
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| ICD-10 | C91.0 | NTBT | attributed | validated |
| ICD-11 | 2A70.1 | E | specific | validated |
| MONDO | 0035940 | E | validated | |
| UMLS | C5680319 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
3
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (1):
- ORPHA:99860Precursor B-cell acute lymphoblastic leukemia
rare hematological diseases; rare neoplastic diseases; rare transplant-related disorders
No children.
4
Genes
7 direct| Gene | Association | Status | HGNC | Ensembl | OMIM | Locus | Name | Source of validation |
|---|---|---|---|---|---|---|---|---|
| CDKN2A | Biomarker tested in | Assessed | HGNC:1787 | ENSG00000147889 | 600160 | 9p21.3 | cyclin dependent kinase inhibitor 2A | 18838613[PMID] |
| IKZF1 | Biomarker tested in | Assessed | HGNC:13176 | ENSG00000185811 | 603023 | 7p12.2 | IKAROS family zinc finger 1 | 19129520[PMID]_23751147[PMID]_19770381[PMID]_18408710[PMID] |
| TP53 | Biomarker tested in | Assessed | HGNC:11998 | ENSG00000141510 | 191170 | 17p13.1 | tumor protein p53 | 34218582[PMID] |
| FLT3 | Disease-causing somatic mutation(s) in | Assessed | HGNC:3765 | ENSG00000122025 | 136351 | 13q12.2 | fms related receptor tyrosine kinase 3 | 16234090[PMID] |
| HLA-C | Major susceptibility factor in | Assessed | HGNC:4933 | ENSG00000204525 | 142840 | 6p21.33 | major histocompatibility complex, class I, C | 25163702[PMID] |
| ABL1 | Part of a fusion gene in | Assessed | HGNC:76 | ENSG00000097007 | 189980 | 9q34.12 | ABL proto-oncogene 1, non-receptor tyrosine kinase | 30561755[PMID] |
| BCR | Part of a fusion gene in | Assessed | HGNC:1014 | ENSG00000186716 | 151410 | 22q11.23 | BCR activator of RhoGEF and GTPase | 23491079[PMID] |
5
Prevalence and incidence
2 records| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Annual incidence | Unknown | — | Worldwide | Class only | Validated | ORPHANET_WHO Classification of Tumours[OTHER] |
| Point prevalence | Unknown | — | Worldwide | Class only | Validated | ORPHANET_WHO Classification of Tumours[OTHER] |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
6
HPO phenotypes
Orphanet has no HPO annotation for this code in this release.
7
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/585909
- This record as JSON: /data/d/585909.json